Clinical trials
Colonic Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Austrian Breast & Colorectal Cancer Study Group | 2 |
| Medical University of Graz | 2 |
| Agendia | 1 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| Hutchison Medipharma Limited | 1 |
| Incyte Corporation | 1 |
| Isofol Medical AB | 1 |
| Johannes Laengle, MD, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 22 |
| Colorectal Neoplasms | 11 |
| Rectal Neoplasms | 9 |
| Breast Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.